Lpl Financial LLC Scynexis Inc Transaction History
Lpl Financial LLC
- $320 Billion
- Q3 2025
A detailed history of Lpl Financial LLC transactions in Scynexis Inc stock. As of the latest transaction made, Lpl Financial LLC holds 53,680 shares of SCYX stock, worth $31,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,680
Previous 63,380
15.3%
Holding current value
$31,671
Previous $42,000
4.76%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SCYX
# of Institutions
47Shares Held
12.5MCall Options Held
0Put Options Held
0-
Avidity Partners Management LP Dallas, TX3.35MShares$1.98 Million1.43% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$1.32 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.04 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$934,1750.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$327,7770.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $19.3M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...